Form 4: MiMedx Director William Hawkins Receives Stock Grant

Director William A. Hawkins acquired 50,913 shares of MiMedx Group, Inc. common stock as part of an annual restricted stock grant.

Summary

• Director William A. Hawkins was granted 50,913 shares of common stock on June 10, 2026.
• The shares were issued at a price of $3.64 per share.
• Following this transaction, the director's total beneficial ownership increased to 254,931 shares.
• The grant is classified as an annual restricted stock award for non-employee directors.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which carries a neutral sentiment.

Positives

• Alignment of director interests with shareholders through increased equity ownership.
• Standard compensation practice for non-employee directors.

Negatives

• None identified.

Risks

• Market price volatility of MiMedx common stock affecting the value of the equity grant.

Future Outlook

The restricted stock award vests upon the earlier of 12 months from the grant date or the next meeting of shareholders.

Industry Context

StockSavvy.ai notes that annual equity grants to non-employee directors are a standard corporate governance practice in the biotechnology and medical device sectors to ensure long-term alignment with shareholder interests.

Comparison to Industry Standards

• The grant structure is consistent with standard equity compensation packages for independent directors in mid-cap healthcare companies.
• Vesting schedules tied to annual shareholder meetings are common practice for board members.

Stakeholder Impact

• Minor dilution impact, though standard for director compensation programs.

Next Steps

• Vesting of the 50,913 shares in 12 months or at the next shareholder meeting.

Key Dates

Keywords

MiMedx, MDXG, Form 4, Insider Trading, Director Compensation, Equity Grant